Just-In: Nasdaq-Listed Firm Announces Hyperliquid Reserve
Highlights
- Eyenovia invests $50M to build HYPE-focused crypto treasury, rebrands to Hyperion DeFi.
- Hyunsu Jung joins as CIO, aims to make firm top Hyperliquid validator.
- Company will stake HYPE, continue eye health business, and register the next-gen Optejet dispenser.
Eyenovia, a digital eye care company, is making a bold shift. It just announced a $50 million private investment from institutional investors. The funds will go toward building a cryptocurrency treasury focused on the HYPE token, native to the Hyperliquid blockchain.
Eyenovia Pioneers HYPE Treasury Strategy
According to the company’s official statement, this move makes Eyenovia, listed on NASDAQ as EYEN, is the first publicly listed U.S. company to hold HYPE in its treasury. The company also plans to rebrand as Hyperion DeFi, changing its ticker symbol to HYPD.
Alongside this strategy shift, Hyunsu Jung has joined as Chief Investment Officer and a board member. The company will issue convertible preferred stock and warrants as part of the investment deal.
If all warrants are exercised, the digital eye firm could raise up to $150 million in total. This is subject to various investor conditions. Eyenovia intends to acquire over one million HYPE tokens. That will make it one of the largest validators on the Hyperliquid blockchain.
It also plans to stake HYPE tokens to earn yields and secure the assets with Anchorage Digital. The company expects the deal to close around June 20, 2025. It is not offering the securities to the public. A separate registration process with the SEC will cover potential future share sales.
Token Integration Marks Strategic Shift Beyond Biotech
CEO Michael Rowe described the move as part of a strategy for diversification and long-term growth. Hyunsu Jung sees Hyperliquid’s native token as one of the most advanced digital assets available. He also emphasized Hyperliquid’s high revenue and fast growth.
The company will continue its main business in eye health. It is developing the next generation of its Optejet dispenser and hopes to register it with the FDA by September 2025. This marks a bold pivot for a biotech company. Eyenovia is now blending eye care innovation with digital asset finance.
HYPE, the token at the center of this shift, is used on Hyperliquid’s Layer-1 blockchain. It supports trading in a non-custodial way using the HyperBFT consensus model. Within the last hour, there hasn’t been any significant change in the token’s price.
While the token currently trades at $41.17, HYPE recently hit an all-time high of $44.75.
- Crypto Market Continues to Plunge, Could 2026 Be the Worst Year?
- XRP News: Ripple Prime Adds Support for Hyperliquid, Providing Wall Street Access to DeFi
- Breaking: Bank of America (BofA) Reveals Holdings in This XRP ETF
- BlackRock Signal Further Downside for Bitcoin And Ethereum As It Moves $170M to Coinbase
- Just-In: Binance Buys Additional 1,315 BTC for SAFU Fund
- Pi Network Price Outlook as Bitcoin Faces a Strong Sell-Off Below $80k
- Bitcoin Price Prediction As US House Passes Government Funding Bill to End Shutdown
- Ondo Price Prediction as MetaMask Integrates 200+ Tokenized U.S. Stocks
- XRP Price Risks Slide to $1 Amid Slumping XRPL Metrics and Burn Rate
- Gold and Silver Prices Turn Parabolic in One Day: Will Bitcoin Mirror the Move?
- Cardano Price Prediction as the Planned CME’s ADA Futures Launch Nears














